Hasil Pencarian - Karim Vermaelen

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses

    Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses oleh Karim Vermaelen

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Dendritic Cell-Based Immunotherapy in Lung Cancer

    Dendritic Cell-Based Immunotherapy in Lung Cancer oleh Dieter Stevens, Dieter Stevens, Joline Ingels, Sandra Van Lint, Sandra Van Lint, Bart Vandekerckhove, Bart Vandekerckhove, Bart Vandekerckhove, Karim Vermaelen, Karim Vermaelen, Karim Vermaelen

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report

    Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report oleh Lander Van Acker, Dieter Stevens, Karim Vermaelen, Veerle Surmont

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer

    Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer oleh Karim Vermaelen, Alvaro Marcos Rubio, Celine Everaert, Eufra Van Damme, Katleen De Preter

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    mRNA in cancer immunotherapy: beyond a source of antigen

    mRNA in cancer immunotherapy: beyond a source of antigen oleh Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Ine Lentacker, Karim Vermaelen, Karine Breckpot, Sandra Van Lint

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    An unusual presentation of a case of human psittacosis

    An unusual presentation of a case of human psittacosis oleh Yannick Vande Weygaerde, Charlot Versteele, Elke Thijs, Anton De Spiegeleer, Jerina Boelens, Daisy Vanrompay, Eva Van Braeckel, Karim Vermaelen

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling

    The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling oleh Jan Van Deun, Pieter Mestdagh, Raija Sormunen, Veronique Cocquyt, Karim Vermaelen, Jo Vandesompele, Marc Bracke, Olivier De Wever, An Hendrix

    Diterbitkan 2014-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial

    Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial oleh Katrien De Wolf, Sylvie Rottey, Karim Vermaelen, Karel Decaestecker, Nora Sundahl, Lizzy De Lobel, Els Goetghebeur, Gert De Meerleer, Nicolaas Lumen, Valérie Fonteyne, Daan De Maeseneer, Piet Ost

    Diterbitkan 2017-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma

    Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma oleh Lennart Raman, Malaïka Van der Linden, Kim Van der Eecken, Karim Vermaelen, Ingel Demedts, Veerle Surmont, Ulrike Himpe, Franceska Dedeurwaerdere, Liesbeth Ferdinande, Yolande Lievens, Kathleen Claes, Björn Menten, Jo Van Dorpe

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817

    First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817 oleh Enriqueta Felip, Helena Linardou, Fabrice Barlesi, Michele Maio, Luis Paz-Ares, Jonathan W Goldman, Karim Vermaelen, Osvaldo Arén Frontera, Erika Rijavec, Kevin Jao, Clarisse Audigier-valette, Han Chang, David R Spigel, Neal E Ready, Tudor-Eliade Ciuleanu, María Rosario García Campelo, Stéphanie Bordenave, Laszlo Urban, Jean-Sébastien Aucoin, Cristina Zannori, Alessandra Curioni Fontecedro, Amparo Sánchez-Gastaldo, Oscar Juan-Vidal, Elena Poddubskaya, Samreen Ahmed, Sunney Li, Joseph Fiore, Angelic Acevedo

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: